State of Wisconsin Investment Board’s Niagen Bioscience NAGE Stock Holding History

State of Wisconsin Investment Board’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$458K	Sell	103,798 -224,067	-68%	-$1.21M	﹤0.01%	2048
2025 Q4	$2.09M	Buy	327,865 +98,902	+43%	+$688K	﹤0.01%	1398
2025 Q3	$2.14M	Buy	228,963 +75,065	+49%	+$758K	﹤0.01%	1333
2025 Q2	$2.22M	Sell	153,898 -6,072	-4%	-$60K	0.01%	1263
2025 Q1	$1.1M	Sell	159,970 -50,730	-24%	-$319K	﹤0.01%	1458
2024 Q4	$1.12M	Buy	210,700 +200,100	+1,888%	+$1.1M	﹤0.01%	1483
2024 Q3	$38.7K	Buy	+10,600	New	+$33.4K	﹤0.01%	2247
2022 Q2	–	Sell	-15,600	Closed	-$37K	–	2884
2022 Q1	$37K	Sell	15,600 -45,400	-74%	-$124K	﹤0.01%	2236
2021 Q4	$228K	Buy	61,000 +13,600	+29%	+$73.4K	﹤0.01%	2066
2021 Q3	$286K	Buy	47,400 +7,200	+18%	+$59.3K	﹤0.01%	1970
2021 Q2	$381K	Buy	40,200 +6,800	+20%	+$59.3K	﹤0.01%	1767
2021 Q1	$295K	Buy	+33,400	New	+$265K	﹤0.01%	1896

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State of Wisconsin Investment Board's NAGE Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Niagen Bioscience (NAGE) stake by 68% in Q1 2026, selling an estimated $1.21M and leaving 103,798 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

State of Wisconsin Investment Board first reported a position in NAGE in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.22M in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

State of Wisconsin Investment Board held 103,798 shares of Niagen Bioscience worth $458K as of Q1 2026.
State of Wisconsin Investment Board sold 224,067 Niagen Bioscience shares in Q1 2026, an estimated $1.21M.
Niagen Bioscience made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2048 holding.
State of Wisconsin Investment Board first reported a position in Niagen Bioscience in Q1 2021 and has held it in 12 quarters since.
State of Wisconsin Investment Board's Niagen Bioscience position peaked at $2.22M in Q2 2025.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.